Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare Semaglutide (Ozempic) and Sitagliptin (Januvia) — clinical data, side effects, and patient experiences.
Ozempic, Wegovy, Rybelsus · GLP-1 Agonist
How it works
Glucagon-like peptide-1 (GLP-1) receptor agonist with 94% homology to human GLP-1. Stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite c...
Approved for
Januvia, ZITUVIMET · DPP-4 Inhibitor
How it works
Inhibits dipeptidyl peptidase-4 (DPP-4) enzyme, slowing the inactivation of incretin hormones GLP-1 and GIP, thereby increasing insulin release and decreasing glucagon levels in a ...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 30 Reddit discussions
Semaglutide
33%
positive
15 threads
Sitagliptin
40%
positive
15 threads
% of discussions mentioning each side effect
Based on 1 verified patient review
No data yet
No data yet
Avg. Duration
0 months
0% still taking
Avg. Duration
18 months
100% still taking
Semaglutide is a GLP-1 Agonist, while Sitagliptin belongs to the DPP-4 Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. Semaglutide is administered via Subcutaneous or Oral, whereas Sitagliptin uses Oral. Route of administration can affect onset of action and patient adherence.
Both medications are approved for Type 2 Diabetes Mellitus. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
Sitagliptin has an average efficacy rating of 7.0/10 and tolerability of 9.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..
Semaglutide carries 3 FDA warnings. Sitagliptin carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.